MedPath

epinephrine

These highlights do not include all the information needed to use EPINEPHRINE INJECTION, USP AUTO-INJECTOR safely and effectively. See full prescribing information for EPINEPHRINE INJECTION, USP AUTO-INJECTOR. Epinephrine injection, USP auto-injector 0.3 mg, 0.15 mg, for intramuscular or subcutaneous use Initial U.S. Approval: 1939

Approved
Approval ID

2d4165c3-16e8-5af8-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 4, 2019

Manufacturers
FDA

Sina Health Inc

DUNS: 047161553

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

epinephrine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70385-2009
Application NumberNDA020800
Product Classification
M
Marketing Category
C73605
G
Generic Name
epinephrine
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateFebruary 4, 2019
FDA Product Classification

INGREDIENTS (6)

SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
CHLOROBUTANOLInactive
Code: HM4YQM8WRC
Classification: IACT
SODIUM BISULFITEInactive
Code: TZX5469Z6I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
EPINEPHRINEActive
Quantity: 0.3 mg in 0.3 mL
Code: YKH834O4BH
Classification: ACTIB

Drug Labeling Information

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 4/30/2014

4 CONTRAINDICATIONS

None.

Key Highlight

None. ( 4)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

epinephrine - FDA Drug Approval Details